Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Nanoparticles As Adjuvant-Vectors For Vaccination

S. Espuelas, C. Gamazo, M. Blanco-Prieto, J. M. Irache
Published 2007 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1517/14712598.4.7.1045
Enhancement of vaccine potency through improved delivery
J. Ulmer (2004)
10.1016/J.IJPHARM.2004.09.002
PLA-PEG particles as nasal protein carriers: the influence of the particle size.
A. Vila (2005)
10.1016/J.JCONREL.2005.03.033
Salmonella-like bioadhesive nanoparticles.
Hesham H. Salman (2005)
10.2105/AJPH.94.11.1931
Research and development of new vaccines against infectious diseases.
M. P. Kieny (2004)
10.1016/S0952-7915(00)00120-5
Immunological concepts of vaccine adjuvant activity.
V. Schijns (2000)
10.1016/J.JCONREL.2004.12.020
Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy.
I. Schoell (2005)
10.1128/IAI.65.2.623-629.1997
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
E. Lindblad (1997)
10.1089/0894268041457183
PEG-PLA nanoparticles as carriers for nasal vaccine delivery.
A. Vila (2004)
10.1080/02652040110055261
Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid.
R. Raghuvanshi (2001)
10.1016/S0264-410X(03)00228-7
Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice.
J. L. Chew (2003)
10.1016/J.VACCINE.2003.12.030
Vaccine adjuvant: it makes the difference.
K. M. Lima (2004)
10.1002/JMV.20100
Induction of HIV‐specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV‐capturing nanospheres in macaques
A. Miyake (2004)
10.1038/nrd1176
Recent advances in the discovery and delivery of vaccine adjuvants
D. O'hagan (2003)
Immune response to uncoupled peptides of foot-and-mouth disease virus.
M. Francis (1987)
10.1080/026520400288454
Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid.
M. P. Desai (2000)
10.1016/S0169-409X(01)00171-5
Chitosan as a novel nasal delivery system for vaccines.
L. Illum (2001)
10.1002/PAT.280
PLA‐PEG nanospheres: new carriers for transmucosal delivery of proteins and plasmid DNA
A. Vila (2002)
10.1163/156856299X00892
Intranasal immunization against influenza virus using polymeric particles.
D. Lemoine (1999)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.1023/A:1019854327540
Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport
I. Behrens (2004)
10.1038/7385
Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
K. Roy (1999)
10.1016/S0034-5288(02)00180-7
Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice.
M. Shephard (2003)
10.1007/s00109-003-0452-9
Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response
M. Kwissa (2003)
10.1023/A:1014474414097
Targeting Vaccines to Dendritic Cells
C. Foged (2004)
10.1023/A:1011922819926
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
M. Tobío (2004)
Delivery systems for molecular vaccination.
N. A. Sheikh (2000)
10.1023/A:1011063232257
Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice
T. Jung (2004)
10.1038/345084A0
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
B. Ensoli (1990)
10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement.
E. Allémann (1997)
10.1016/J.VACCINE.2003.09.044
Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
M. Bivas-Benita (2004)
10.1046/j.1523-5378.1999.09046.x
Oral Immunization with Helicobacter pylori‐Loaded Poly( d, l‐Lactide‐Co‐Glycolide) Nanoparticles
S. Kim (1999)
10.1111/j.1365-2222.2004.01909.x
Interleukin‐10, T regulatory cells and specific allergy treatment
K. Blaser (2004)
10.1016/S0378-5173(03)00377-6
Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies.
M. Bivas-Benita (2003)
10.1146/ANNUREV.IMMUNOL.22.012703.104558
Self- and nonself-recognition by C-type lectins on dendritic cells.
T. B. Geijtenbeek (2004)
10.1111/j.1365-2222.2004.01884.x
Allergen‐loaded biodegradable poly(d,l‐lactic‐co‐glycolic) acid nanoparticles down‐regulate an ongoing Th2 response in the BALB/c mouse model
I. Schoell (2004)
10.1016/J.JCONREL.2004.04.026
Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
A. Vila (2004)
10.1023/A:1022271020390
Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages
L. Thiele (2004)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1586/14760584.1.2.215
Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells
L. Thiele (2002)
10.1046/j.1365-2249.2003.02144.x
Cytokine‐based immunointervention in the treatment of autoimmune diseases
L. Adorini (2003)
10.1016/S0264-410X(02)00168-8
The global impact of vaccines containing aluminium adjuvants.
C. J. Clements (2002)
10.1046/j.1440-1711.2001.01011.x
Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes
J. Reece (2001)
10.1016/S0753-3322(01)00073-7
Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes.
H. Le Buanec (2001)
10.1517/17425247.2.2.205
Bioadhesive properties of pegylated nanoparticles
K. Yoncheva (2005)
10.1016/0168-3659(91)90040-K
Nanoparticle-based dmg delivery systems
J. Kreuter (1991)
10.1016/J.VACCINE.2005.04.021
Effective nasal influenza vaccine delivery using chitosan.
R. Read (2005)
10.1128/CDLI.9.5.1021-1024.2002
Calcium Phosphate Nanoparticles Induce Mucosal Immunity and Protection against Herpes Simplex Virus Type 2
Q. He (2002)
10.1002/JMV.10279
Mucosal immunization with inactivated HIV‐1‐capturing nanospheres induces a significant HIV‐1‐specific vaginal antibody response in mice
Takami Akagi (2003)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar